{"id":"https://openalex.org/W2185684752","doi":null,"title":"Studies on the pharmacology of D-lysergic acid cycloalkylamides.","display_name":"Studies on the pharmacology of D-lysergic acid cycloalkylamides.","alternate_titles":[],"publication_year":1958,"publication_date":"1958-05-01","ids":{"openalex":"https://openalex.org/W2185684752","mag":"2185684752","pmid":"https://pubmed.ncbi.nlm.nih.gov/13545891"},"language":"fr","primary_location":{"id":"pmid:13545891","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/13545891","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives internationales de pharmacodynamie et de therapie","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2185684752"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061966166","display_name":"Zdenek Votava","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Z VOTAVA","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051789657","display_name":"I Podvalov\u00e1","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"I PODVALOVA","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5112256693","display_name":"M. Semonsk\u00fd","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M SEMONSKY","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":11,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"115","issue":"1-2","first_page":"114","last_page":"130"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12649","display_name":"Alkaloids: synthesis and pharmacology","score":0.7451000213623047,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12649","display_name":"Alkaloids: synthesis and pharmacology","score":0.7451000213623047,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12553","display_name":"Psychedelics and Drug Studies","score":0.1509000062942505,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.04879999905824661,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lysergic-acid-diethylamide","display_name":"lysergic acid diethylamide","score":0.8970000147819519},{"id":"https://openalex.org/keywords/lsd","display_name":"LSD","score":0.6150000095367432},{"id":"https://openalex.org/keywords/ergotamine-derivatives","display_name":"ergotamine derivatives","score":0.7269999980926514},{"id":"https://openalex.org/keywords/ergometrine","display_name":"ergometrine","score":0.9399999976158142},{"id":"https://openalex.org/keywords/central-nervous-system-action","display_name":"central nervous system action","score":0.6660000085830688},{"id":"https://openalex.org/keywords/serotonin","display_name":"serotonin","score":0.9369999766349792},{"id":"https://openalex.org/keywords/oxytocic-effect","display_name":"oxytocic effect","score":0.6980000138282776},{"id":"https://openalex.org/keywords/blood-albumin","display_name":"blood albumin","score":0.5849999785423279},{"id":"https://openalex.org/keywords/psychosis","display_name":"psychosis","score":0.3109999895095825}],"concepts":[{"id":"https://openalex.org/C2778889179","wikidata":"https://www.wikidata.org/wiki/Q415837","display_name":"Lysergic acid","level":2,"score":0.976384162902832},{"id":"https://openalex.org/C2779871769","wikidata":"https://www.wikidata.org/wiki/Q23118","display_name":"Lysergic acid diethylamide","level":4,"score":0.8933470249176025},{"id":"https://openalex.org/C2777512643","wikidata":"https://www.wikidata.org/wiki/Q424508","display_name":"Ergometrine","level":2,"score":0.7993118762969971},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6300066709518433},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5852358937263489},{"id":"https://openalex.org/C2779929513","wikidata":"https://www.wikidata.org/wiki/Q419186","display_name":"Ergotamine","level":3,"score":0.5641988515853882},{"id":"https://openalex.org/C2776125444","wikidata":"https://www.wikidata.org/wiki/Q193140","display_name":"Mescaline","level":3,"score":0.5202727913856506},{"id":"https://openalex.org/C2909645108","wikidata":"https://www.wikidata.org/wiki/Q10705510","display_name":"Tryptamines","level":3,"score":0.433065265417099},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.4200012683868408},{"id":"https://openalex.org/C124315065","wikidata":"https://www.wikidata.org/wiki/Q194270","display_name":"Hallucinogen","level":2,"score":0.2992693781852722},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.23363393545150757},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.19227218627929688},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17838475108146667},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1682634949684143},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.08169135451316833},{"id":"https://openalex.org/C2778541695","wikidata":"https://www.wikidata.org/wiki/Q133823","display_name":"Migraine","level":2,"score":0.0},{"id":"https://openalex.org/C2777135210","wikidata":"https://www.wikidata.org/wiki/Q409439","display_name":"Tryptamine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D008237","descriptor_name":"Lysergic Acid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008238","descriptor_name":"Lysergic Acid Diethylamide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:13545891","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/13545891","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives internationales de pharmacodynamie et de therapie","raw_type":"Journal Article"},{"id":"mag:2185684752","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/13545891","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2056388351","https://openalex.org/W1974814463","https://openalex.org/W2991486694","https://openalex.org/W1995108501","https://openalex.org/W2256156657","https://openalex.org/W2339342020","https://openalex.org/W2185451265","https://openalex.org/W7096337247","https://openalex.org/W1999491170"],"abstract_inverted_index":{"Recently":[0],"much":[1],"interest":[2],"has":[3,121],"been":[4,45,122],"concentrated":[5],"on":[6,38,81,156,181],"the":[7,11,25,50,55,59,82,157,163],"pharmacological":[8,142],"properties":[9,143],"of":[10,15,20,24,49,52,61,85,113,138,144,154,159,175],"partial":[12],"synthetic":[13],"derivatives":[14,174],"d-lysergic":[16,86,176],"acid.":[17],"By":[18],"hydrogenation":[19],"ergotamine":[21],"and":[22,71,128],"alkaloids":[23],"ergotoxine":[26],"group":[27],"(ergoeristine,":[28],"ergokryptine,":[29],"ergocornine),":[30],"new":[31],"substances":[32],"with":[33,75,141],"very":[34],"pronounced":[35],"adreno-sympatolytic":[36],"effect":[37,68],"central":[39,83],"mechanism":[40],"(i,":[41],"2,":[42],"3)":[43],"have":[44,170,191],"prepared.":[46],"The":[47,79,111],"substitution":[48],"rest":[51,60],"L(+)-2-aminopropanol-(0":[53],"in":[54,73,93,103,119,124,131],"ergometrine":[56,76],"molecule":[57],"by":[58,108],"(+)-2-aminobutanol-(t)":[62],"leads":[63],"to":[64,98,116],"methylergobasine,":[65],"whose":[66],"oxytocic":[67],"is":[69,185],"enhanced":[70],"prolonged":[72],"comparison":[74],"(4,":[77],"5).":[78],"investigations":[80],"action":[84,153,184],"acid":[87,177],"diethylamide":[88],"(LSD)":[89],"mean":[90],"further":[91],"progress":[92],"this":[94],"group.":[95],"Its":[96],"ability":[97],"produce":[99],"temporary":[100],"psychotic":[101],"changes":[102,130],"man":[104],"was":[105],"first":[106],"described":[107],"STOLL":[109],"(6).":[110],"similarity":[112],"these":[114,151],"effects":[115,158],"pathological":[117],"states":[118],"psychiatry":[120],"shown":[123,171],"both":[125],"clinical":[126],"manifestations":[127],"biochemical":[129],"blood":[132],"albumins":[133],"(7).":[134],"A":[135],"great":[136],"number":[137],"papers":[139],"deal":[140],"LSD":[145,155],"(8,":[146],"9,":[147],",o,":[148],",x).":[149],"From":[150],"inhibitory":[152],"5-hydroxytryptamine":[160],"(5-HT)":[161],"are":[162],"most":[164],"interesting":[165],"(I2,":[166],"13).":[167],"Further":[168],"experiments":[169],"that":[172],"other":[173],"although":[178],"their":[179],"influence":[180],"higher":[182],"nervous":[183],"low":[186],"(i4,":[187],",5)":[188],",":[189],"also":[190],"a":[192],"strong":[193],"antiserotonin":[194],"action.":[195]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2185684752","counts_by_year":[],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
